Cargando…
Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Lewy bodies (LBs) are complex, intracellular inclusions that are common pathological features of many neurodegenerative diseases. They consist largely of aggregated forms of the protein alpha-Synuclein (α-Syn), which misfolds to give rise to beta-sheet rich amyloid fibrils. The aggregation of monome...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611971/ https://www.ncbi.nlm.nih.gov/pubmed/34819159 http://dx.doi.org/10.1186/s40478-021-01288-2 |
_version_ | 1784603395285319680 |
---|---|
author | Marotta, Nicholas P. Ara, Jahan Uemura, Norihito Lougee, Marshall G. Meymand, Emily S. Zhang, Bin Petersson, E. James Trojanowski, John Q. Lee, Virginia M.-Y. |
author_facet | Marotta, Nicholas P. Ara, Jahan Uemura, Norihito Lougee, Marshall G. Meymand, Emily S. Zhang, Bin Petersson, E. James Trojanowski, John Q. Lee, Virginia M.-Y. |
author_sort | Marotta, Nicholas P. |
collection | PubMed |
description | Lewy bodies (LBs) are complex, intracellular inclusions that are common pathological features of many neurodegenerative diseases. They consist largely of aggregated forms of the protein alpha-Synuclein (α-Syn), which misfolds to give rise to beta-sheet rich amyloid fibrils. The aggregation of monomers into fibrils occurs readily in vitro and pre-formed fibrils (PFFs) generated from recombinant α-Syn monomers are the basis of many models of LB diseases. These α-Syn PFFs recapitulate many pathological phenotypes in both cultured cells and animal models including the formation of α-Syn rich, insoluble aggregates, neuron loss, and motor deficits. However, it is not clear how closely α-Syn PFFs recapitulate the biological behavior of LB aggregates isolated directly from patients. Direct interrogation of the cellular response to LB-derived α-Syn has thus far been limited. Here we demonstrate that α-Syn aggregates derived from LB disease patients induce pathology characterized by a prevalence of large somatic inclusions that is distinct from the primarily neuritic pathology induced by α-Syn PFFs in our cultured neuron model. Moreover, these LB-derived aggregates can be amplified in vitro using recombinant α-Syn to generate aggregates that maintain the unique, somatic pathological phenotype of the original material. Amplified LB aggregates also showed greater uptake in cultured neurons and greater pathological burden and more rapid pathological spread in injected mouse brains, compared to α-Syn PFFs. Our work indicates that LB-derived α-Syn from diseased brains represents a distinct conformation species with unique biological activities that has not been previously observed in fully recombinant α-Syn aggregates and demonstrate a new strategy for improving upon α-Syn PFF models of synucleinopathies using amplified LBs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-021-01288-2. |
format | Online Article Text |
id | pubmed-8611971 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86119712021-11-29 Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro Marotta, Nicholas P. Ara, Jahan Uemura, Norihito Lougee, Marshall G. Meymand, Emily S. Zhang, Bin Petersson, E. James Trojanowski, John Q. Lee, Virginia M.-Y. Acta Neuropathol Commun Research Lewy bodies (LBs) are complex, intracellular inclusions that are common pathological features of many neurodegenerative diseases. They consist largely of aggregated forms of the protein alpha-Synuclein (α-Syn), which misfolds to give rise to beta-sheet rich amyloid fibrils. The aggregation of monomers into fibrils occurs readily in vitro and pre-formed fibrils (PFFs) generated from recombinant α-Syn monomers are the basis of many models of LB diseases. These α-Syn PFFs recapitulate many pathological phenotypes in both cultured cells and animal models including the formation of α-Syn rich, insoluble aggregates, neuron loss, and motor deficits. However, it is not clear how closely α-Syn PFFs recapitulate the biological behavior of LB aggregates isolated directly from patients. Direct interrogation of the cellular response to LB-derived α-Syn has thus far been limited. Here we demonstrate that α-Syn aggregates derived from LB disease patients induce pathology characterized by a prevalence of large somatic inclusions that is distinct from the primarily neuritic pathology induced by α-Syn PFFs in our cultured neuron model. Moreover, these LB-derived aggregates can be amplified in vitro using recombinant α-Syn to generate aggregates that maintain the unique, somatic pathological phenotype of the original material. Amplified LB aggregates also showed greater uptake in cultured neurons and greater pathological burden and more rapid pathological spread in injected mouse brains, compared to α-Syn PFFs. Our work indicates that LB-derived α-Syn from diseased brains represents a distinct conformation species with unique biological activities that has not been previously observed in fully recombinant α-Syn aggregates and demonstrate a new strategy for improving upon α-Syn PFF models of synucleinopathies using amplified LBs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-021-01288-2. BioMed Central 2021-11-24 /pmc/articles/PMC8611971/ /pubmed/34819159 http://dx.doi.org/10.1186/s40478-021-01288-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Marotta, Nicholas P. Ara, Jahan Uemura, Norihito Lougee, Marshall G. Meymand, Emily S. Zhang, Bin Petersson, E. James Trojanowski, John Q. Lee, Virginia M.-Y. Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro |
title | Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro |
title_full | Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro |
title_fullStr | Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro |
title_full_unstemmed | Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro |
title_short | Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro |
title_sort | alpha-synuclein from patient lewy bodies exhibits distinct pathological activity that can be propagated in vitro |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611971/ https://www.ncbi.nlm.nih.gov/pubmed/34819159 http://dx.doi.org/10.1186/s40478-021-01288-2 |
work_keys_str_mv | AT marottanicholasp alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro AT arajahan alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro AT uemuranorihito alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro AT lougeemarshallg alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro AT meymandemilys alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro AT zhangbin alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro AT peterssonejames alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro AT trojanowskijohnq alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro AT leevirginiamy alphasynucleinfrompatientlewybodiesexhibitsdistinctpathologicalactivitythatcanbepropagatedinvitro |